Solara Active Pharma Sciences Ltd
NSE:SOLARA

Watchlist Manager
Solara Active Pharma Sciences Ltd Logo
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Watchlist
Price: 799.35 INR 4.98% Market Closed
Market Cap: 38.4B INR
Have any thoughts about
Solara Active Pharma Sciences Ltd?
Write Note

Solara Active Pharma Sciences Ltd
Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Solara Active Pharma Sciences Ltd
Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Minority Interest
â‚ą26.7m
CAGR 3-Years
4%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Minority Interest
â‚ą936.8m
CAGR 3-Years
-27%
CAGR 5-Years
-21%
CAGR 10-Years
3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Minority Interest
â‚ą2.6B
CAGR 3-Years
-55%
CAGR 5-Years
-41%
CAGR 10-Years
-20%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Minority Interest
â‚ą2.1B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Solara Active Pharma Sciences Ltd
Glance View

Market Cap
38.4B INR
Industry
Pharmaceuticals

Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2018-06-27. The firm is involved in contract manufacturing and development services for global companies. Its commercial products include Aprepitant (Antiemetic), Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone Hcl (Anxiolytic), Cevimeline Hydrochloride (Muscarinic Agonist), Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Disulfiram (Chronic Alcoholism), Edaravone (Recovery Of Stroke), Etomidate (Anesthetics), Felbamate (Anticonvulsant), Flecainide Acetate (Anti-Arrhythmic Agent), Rifaximin (Antibiotic), S-Ibuprofen (Anti-Inflammatory), Oseltamivir Phosphate(Antiviral) and Levetiracetam (Anticonvulsant). The company provides services, such as synthetic development, analytical development, process engineering, and regulatory services.

SOLARA Intrinsic Value
539.44 INR
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Solara Active Pharma Sciences Ltd's Minority Interest?
Minority Interest
26.7m INR

Based on the financial report for Sep 30, 2024, Solara Active Pharma Sciences Ltd's Minority Interest amounts to 26.7m INR.

What is Solara Active Pharma Sciences Ltd's Minority Interest growth rate?
Minority Interest CAGR 5Y
-9%

Over the last year, the Minority Interest growth was 8%. The average annual Minority Interest growth rates for Solara Active Pharma Sciences Ltd have been 4% over the past three years , -9% over the past five years .

Back to Top